ADSlay

Quince Therapeutics $QNCX, DD account. Disclaimer: No financial advise to buy or sell any stocks. Not affiliated. I have a long position.

[Quince Therapeutics @Quince_Tx]

$QNCX Investors: We are pleased to participate at the British Paediatric Neurology Association 2026 Annual Meeting with a poster presentation highlighting previously published safety data from the long-term treatment of children with A-T. Learn more here: https://t.co/SHh49IB4Ps

[Antonio Costa @ACInvestorBlog]

$QNCX Quince Therapeutics Presents Safety Data from Long-Term eDSP Treatment in Children with Ataxia-Telangiectasia at British Paediatric Neurology Association Annual Meeting

[ADSlay @slay_ad]

$QNCX

[Bull Stock Picks @Bullstkpicks]

One month to go and I expect very positive results. Remember this opens up many other diseases that this platform will be able to go after. This is as much about a platform as it is this one disease. That isn’t priced into the stock at all. Positive data on this disease pushes this over $20, then other indications started getting priced in as potential and that pushes us much much higher

[Bull Stock Picks @Bullstkpicks]

One month to go and I expect very positive results. Remember this opens up many other diseases that this platform will be able to go after. This is as much about a platform as it is this one disease. That isn’t priced into the stock at all. Positive data on this disease pushes this over $20, then other indications started getting priced in as potential and that pushes us much much higher

[Braden TeWinkel @braden_tewinkel]

$qncx multiple $300k buys today leading to all this green. Whales are loading the boat!!

[The Westie of Wall Street @westieofwallst]

good thread on $QNCX

[Omni @Omnitrader69]

Today feels like yesterday, SPY green while a bunch of my stuff is tanking for whatever reason.

$OCUL standout strength though. $QNCX some buyers again also.

[ADSlay @slay_ad]

$QNCX 👇

[Wolf @DeltaGammaThet2]

CEO Dirk Thye recently received 1 million in options (4 year vest, strike of $3.08 - ATM). Board members have opted to receive retainers and compensation in all options, a break from the past where it was a mix of options + cash.

Incentives are aligned here.

[Wolf @DeltaGammaThet2]

CEO Dirk Thye recently received 1 million in options (4 year vest, strike of $3.08 - ATM). Board members have opted to receive retainers and compensation in all options, a break from the past where it was a mix of options + cash.

Incentives are aligned here.

[Wolf @DeltaGammaThet2]

.. we get a powerful result. I can see why management is so bullish. It would be hard to argue why a clinician would not be willing to offer a therapy with nearly 3x the potency for a young family devastated by the diagnosis of AT.

[Wolf @DeltaGammaThet2]

If QNCX can repeat the results from the 6-9 age group, this should translate to an approximate 2.5-3.0x MORE POWERFUL treatment than IntraBio's recent results.

Translating (and it is an approximation) IntraBio's SARA score and the ATTeST mICARS score to the RmICARS...

[Lovejoy @LovejoyVapor]

@VIPSheffTrades I like how enthusiastic you are, but boy would I like to see some insider buying at $QNCX!

[Wolf @DeltaGammaThet2]

Bullish $QNCX.

Some perceive IntraBio's recent phase 3 as a threat to QNCX's upcoming top-line results. I would argue that knowing IntraBio's results, the forthcoming QNCX top-line has been de-risked.

[Zach TeWinkel @zachtewinkel]

$QNCX - a must watch interview. Huge upside here https://t.co/61kpDO6kJq

[ADSlay @slay_ad]

@fcminaker Agreed and Dirk said so in above clip — "ten years ago". But good example of a biotech's journey with a happy ending that touches $QNCX so what if even remotely

[ADSlay @slay_ad]

Totally missed this! Goddammmnn!!

$QNCX CEO/CMO and COO are both met at $CDTX that recently got acquired for $9.2 billion by Merck! Wow!

Less bearish now.

$XBI

Listen around 7 minute mark 👇

[Quince Therapeutics @Quince_Tx]

Listen in to a recent conversation Quince’s CEO & CMO Dr. Dirk Thye had with Max Brennan at The BioHub Podcast. Check it out here:
https://t.co/zI17BQLhlN
$QNCX #biotech #raredisease #innovation

[ADSlay @slay_ad]

Woah! $QNCX team is pretty much $CDTX! Wow! Had no idea. Quince CEO/CMO Thye was Cidara's first CMO! And that's where he met QNCX COO Brendan Hannah, wow!

Daammmnn!!

$XBI

Ph3 readout anytime next month

[Quince Therapeutics @Quince_Tx]

Listen in to a recent conversation Quince’s CEO & CMO Dr. Dirk Thye had with Max Brennan at The BioHub Podcast. Check it out here:
https://t.co/zI17BQLhlN
$QNCX #biotech #raredisease #innovation

[Quince Therapeutics @Quince_Tx]

Listen in to a recent conversation Quince’s CEO & CMO Dr. Dirk Thye had with Max Brennan at The BioHub Podcast. Check it out here:
https://t.co/zI17BQLhlN
$QNCX #biotech #raredisease #innovation

[ADSlay @slay_ad]

@fcminaker Few days ago, some Board members were also awarded options at a strike price of $3.

[ADSlay @slay_ad]

$QNCX

More Form 4s today -- this time Thye and Hannah.

Granted they're all options, make what you will.

Interesting they're from just today with greater strike price than last batch of Form 4s 🤔🤔🤔 hmmm

$XBI asymmetrical bet binary event